| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| PQ912 |
化合物PQ912 |
1276021-65-8 |
詳細(xì)
|
| HI-B1 |
β-catenin-IN-2 |
1458664-10-2 |
詳細(xì)
|
| MONNA |
2-(4-甲氧基萘-2-基氨基)-5-硝基苯甲酸 |
1572936-83-4 |
詳細(xì)
|
| 3-Mercaptopropanyl-NHS ester |
3-巰基丙烷基-N-羥基琥珀酰亞胺酯 |
117235-10-6 |
詳細(xì)
|
| TM2-115 |
TM2-115 |
1197196-47-6 |
詳細(xì)
|
| H2-Gamendazole |
化合物H2-GAMENDAZOLE |
877768-84-8 |
詳細(xì)
|
| SR31527 |
SR31527 |
311814-78-5 |
詳細(xì)
|
| MDL-800 |
2-[[(5-溴-4-氟-2-甲基苯基)氨基]磺?；鵠-5-[[(3,5-二氯苯基)磺?；鵠氨基]苯甲酸甲酯 |
2275619-53-7 |
詳細(xì)
|
| ICI-199441 hydrochloride |
化合物 T22849 |
115199-84-3 |
詳細(xì)
|
| TLR7 agonist T7 (1V209) |
1V209 |
1062444-54-5 |
詳細(xì)
|
| VUF10661 |
|
914291-63-7 |
詳細(xì)
|
| Gardiquimod |
4-氨基-2-[(乙基氨基)甲基]-ALPHA,ALPHA-二甲基-1H-咪唑并[4,5-C]喹啉-1-乙醇 |
1020412-43-4 |
詳細(xì)
|
| AP1189 |
化合物AP1189 ACETATE |
959850-74-9 |
詳細(xì)
|
| AqB011 |
3-(BUTYLAMINO)-4-PHENOXY-N-(PYRIDIN-3-YLMETHYL)-5-SULFAMOYLBENZAMIDE |
1021869-49-7 |
詳細(xì)
|
| Fluorofurimazine |
6-(3-氨基-2-氟苯基)-8-(2-氟芐基)-2-(呋喃-2-基甲基)咪唑并[1,2-A]吡嗪-3(7H)-酮 |
2412089-96-2 |
詳細(xì)
|
| NCGC00063279 |
化合物 NCGC00063279 |
714932-54-4 |
詳細(xì)
|
| CK-869 |
CK-869 |
388592-44-7 |
詳細(xì)
|
| CY-09 |
4-[[2-硫代-3-(3-三氟甲基芐基)-4-氧代噻唑烷-5-亞基]甲基]苯甲酸 |
1073612-91-5 |
詳細(xì)
|
| AMG7905 |
6-Benzothiazolamine, N-[6-[2-[(cyclohexylmethyl)amino]-4-(trifluoromethyl)phenyl]-4-pyrimidinyl]- |
1026876-55-0 |
詳細(xì)
|
| NRX-252262 |
化合物NRX-252262 |
2438637-61-5 |
詳細(xì)
|
| CU-3 |
N-[(5Z)-5-[(E)-3-(furan-2-yl)prop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzenesulfonamide |
861123-84-4 |
詳細(xì)
|
| ENMD-1068 Hydrobromide |
ENMD 547 |
644961-61-5 |
詳細(xì)
|
| CCR2-RA-[R |
(5R)-4-乙?；?1-(4-氯-2-氟苯基)-5-環(huán)己基-1,5-二氫-3-羥基-2H-吡咯-2-酮 |
512177-83-2 |
詳細(xì)
|
| GSK2163632A |
化合物 T24106 |
1123163-20-1 |
詳細(xì)
|
| JPM-OEt |
N-[[L-TRANS-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL]-L-LEUCYL-3-(P-HYDROXYPHENYL)ETHYLAMIDE |
262381-84-0 |
詳細(xì)
|
| 9-ING-41 |
9-ING-41 |
1034895-42-5 |
詳細(xì)
|
| ML 00253764 hydrochloride |
ML 00253764 Hydrochloride |
681847-92-7 |
詳細(xì)
|
| Fulvene-5 |
(2E)-3-cyclopenta-2,4-dien-1-ylidene-2-(3-cyclopenta-2,4-dien-1-ylidene-1H-indol-2-ylidene)-1H-indole |
1075723-01-1 |
詳細(xì)
|
| Aurachin D |
橙標(biāo)樁囊菌素 D |
108354-13-8 |
詳細(xì)
|
| T6167923 |
4-((3-bromophenyl)sulfonyl)-N-(1-(thiophen-2-yl)ethyl)piperazine-1-carboxamide |
1090528-71-4 |
詳細(xì)
|
| APX001 |
化合物 T23749 |
1169701-00-1 |
詳細(xì)
|
| ALE-0540 |
ALE-0540 |
234779-34-1 |
詳細(xì)
|
| S-Propyl-L-cysteine |
S-正丙基-L-半胱氨酸 |
1115-93-1 |
詳細(xì)
|
| FD-1080 |
FD-1080 |
1151666-58-8 |
詳細(xì)
|
| BH-IAA |
1H-Indole-3-acetic acid, α-[6-[[(1,1-dimethylethoxy)carbonyl]amino]hexyl]- |
1020201-82-4 |
詳細(xì)
|
| XX-650-23 |
XX-650-23 |
117739-40-9 |
詳細(xì)
|
| NPD10084 |
|
1040706-91-9 |
詳細(xì)
|
| PC58538 |
化合物 T28305 |
434910-94-8 |
詳細(xì)
|
| PAOPA |
化合物 T23121 |
114200-31-6 |
詳細(xì)
|
| FR054 |
(3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氫-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸鹽 |
10378-06-0 |
詳細(xì)
|
| GF-61 |
|
1094369-54-6 |
詳細(xì)
|
| LuAA33810 |
化合物 LU AA33810 |
304008-29-5 |
詳細(xì)
|
| SR 16584 |
SR 16584 |
1150153-86-8 |
詳細(xì)
|
| 2-Naphthalenecarboxamide, N-[(1S)-1-(2-pyridinyl)ethyl]-5-[4-(trifluoromethyl)phenyl]- |
化合物VT104 |
2417718-25-1 |
詳細(xì)
|
| Bozepinib |
化合物 T23813 |
1207993-83-6 |
詳細(xì)
|
| BI-9627 |
BI-9627 |
1204329-34-9 |
詳細(xì)
|
| JAY2-22-33 |
2-(Methyl-pyridin-3-ylMethyl-aMino)-ethanol |
121489-14-3 |
詳細(xì)
|
| LDN-211904 Oxalate |
N-(2-氯苯基)-6-(4-哌啶基)-咪唑并[1,2-A]吡啶-3-甲酰胺草酸鹽 |
1198408-78-4 |
詳細(xì)
|
| PF-46396 |
PF-46396 |
1207481-21-7 |
詳細(xì)
|
| Symplostatin 4 |
化合物 GALLINAMIDE A |
1208232-55-6 |
詳細(xì)
|
| B022 |
4-(1-(2-氨基-5-氯嘧啶-4-基)-2-(噻唑-2-基)-3-丁炔-2-醇 |
1202764-53-1 |
詳細(xì)
|
| GS-441524 |
GS-441524 |
1191237-69-0 |
詳細(xì)
|
| Arcyriaflavin A |
12,13-DIHYDRO-5H-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7(6H)-DIONE |
118458-54-1 |
詳細(xì)
|
| GW296115X |
|
118458-58-5 |
詳細(xì)
|
| MRT68921 |
MRT68921 |
1190379-70-4 |
詳細(xì)
|
| 1-Pyrrolidinecarboxamide, 2-(4-methoxyphenyl)-N-[2-(4-morpholinyl)-5-(trifluoromethyl)phenyl]- |
FAK ACTIVATOR 1 |
1211825-25-0 |
詳細(xì)
|
| CycLuc1 |
CYCLUC1 |
1247879-16-8 |
詳細(xì)
|
| N2-OH-PhIP |
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine |
124489-20-9 |
詳細(xì)
|
| CDE-096 |
化合物 T25217 |
1228357-04-7 |
詳細(xì)
|
| NAB-14 |
化合物 NAB-14 |
1237541-73-9 |
詳細(xì)
|
| ZMB741 |
|
1233238-87-3 |
詳細(xì)
|
| Enadoline |
依那朵林 |
124378-77-4 |
詳細(xì)
|
| NCT-504 |
NCT-504 |
1222765-97-0 |
詳細(xì)
|
| RO2959 Hydrochloride |
|
1220022-06-9 |
詳細(xì)
|
| DDD85646 Hydrochloride |
DDD85646 |
1215010-55-1 |
詳細(xì)
|
| AM6545 |
5-(4-[4-cyanobut-1-ynyl]phenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(1,1-dioxo-thiomorpholino)-1H-pyrazole-3-carboxamide |
1245626-05-4 |
詳細(xì)
|
| SOMG-833 |
SOMG-833 |
1268264-10-3 |
詳細(xì)
|
| VU0360172 Hydrochloride |
VU 0360172 |
1309976-62-2 |
詳細(xì)
|
| CX-5011 |
SODIUM 5-(3-ETHYNYLPHENYLAMINO)PYRIMIDO[4,5-C]QUINOLINE-8-CARBOXYLATE |
1333382-30-1 |
詳細(xì)
|
| KH-CB19 |
CS-2131 |
1354037-26-5 |
詳細(xì)
|
| GSK2193874 |
GSK2193874游離態(tài) |
1336960-13-4 |
詳細(xì)
|
| PK-THPP |
1-{1-[6-(biphenyl-4-ylcarbonyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl]piperidin-4-yl}butan-1-one |
1332454-07-5 |
詳細(xì)
|
| HA-155 |
HA-155 |
1229652-22-5 |
詳細(xì)
|
| GSK114 |
GSK-114 2Hcl |
1301760-19-9 |
詳細(xì)
|
| Amg-232 |
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(異丙基磺?；?-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸 |
1352066-68-2 |
詳細(xì)
|
| UNC7938 |
ethyl 8-(2-(dimethylamino)ethylamino)-2,3-diphenylpyrido[2,3-b]pyrazin-6-ylcarbamate |
1347749-97-6 |
詳細(xì)
|
| BRD5529 |
BRD5529 |
1358488-78-4 |
詳細(xì)
|
| 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-6-[2-[4-(diphenylamino)phenyl]ethenyl]- |
|
1283604-05-6 |
詳細(xì)
|
| GSK205 |
GSK205 |
1263068-83-2 |
詳細(xì)
|
| F2-luc |
|
1260754-66-2 |
詳細(xì)
|
| NVP-2 |
化合物NVP-2 |
1263373-43-8 |
詳細(xì)
|
| Bicyclo[2.2.1]heptane-1-carboxylic acid, 4-[2-[9-[(4-fluorophenyl)methyl]-5,6,8,9-tetrahydro-7H-pyrrolo[2,3-b:5,4-c']dipyridin-7-yl]-2-oxoethyl]- |
化合物ONO-8430506 |
1354805-08-5 |
詳細(xì)
|
| NNP9 |
|
1644449-24-0 |
詳細(xì)
|
| CDK8-IN-16 |
CDK8-IN-1 |
1629633-48-2 |
詳細(xì)
|
| (R)-9bMS |
|
1655527-68-6 |
詳細(xì)
|
| V-9302 |
V-9302 |
1855871-76-9 |
詳細(xì)
|
| JWG-071 |
JWG-071 |
2250323-50-1 |
詳細(xì)
|
| OSU-T315 (1,3-regioisomer) |
OSU-T315 |
2070015-22-2 |
詳細(xì)
|
| RWJ 67657 |
4-(4-氟苯基)-2-(4-羥基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 |
215303-72-3 |
詳細(xì)
|
| QPX7728 |
QPX7728 |
2170834-63-4 |
詳細(xì)
|
| JMS-053 |
化合物 JMS-053 |
1954650-11-3 |
詳細(xì)
|
| UAB30 |
|
205252-57-9 |
詳細(xì)
|
| SPOP-IN-6b |
SPOP-IN-6b |
2136270-20-5 |
詳細(xì)
|
| APG-1387 |
APG-1387 |
1570231-89-8 |
詳細(xì)
|
| Rpn11-IN-1 |
Capzimin |
2084857-65-0 |
詳細(xì)
|
| ARI-3099 hydrochloride |
化合物 T26658 |
1432499-49-4 |
詳細(xì)
|
| Jarin-1 |
Jarin-1 |
1212704-51-2 |
詳細(xì)
|
| zr17-2 |
|
1263893-98-6 |
詳細(xì)
|
| DIM-C-pPhCO2Me |
DIM-C-pPhCO2Me |
151358-48-4 |
詳細(xì)
|
| UAMC-1110 |
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 |
1448440-52-5 |
詳細(xì)
|
| GSK1059865 |
1191044-58-2 |
1191044-58-2 |
詳細(xì)
|